New drug for the treatment of exocrine pancreatic insufficiency

http://markets.businessinsider.com/news/stocks/AzurRx-BioPharma-and-Mayoly-Spindler-Announce-MS1819-SD-Investigational-Medicinal-Product-Dossier-IMPD-Submission-1005030890

AzurRx BioPharma and Mayoly Spindler Announce MS1819-SD Investigational Medicinal Product Dossier (IMPD) Submission

AzurRx BioPharma Inc. (NASDAQ:AZRX) (“AzurRx” or the Continue reading New drug for the treatment of exocrine pancreatic insufficiency